AGH.AU · Althea Group Holdings Limited

-

Please sign in to comment on AGH.AU

1 Comment

Admin

4 years, 1 month ago

Althea Group Holdings Limited is currently in a long term downtrend where the price is trading 24.2% below its 200 day moving average.

From a valuation standpoint, the stock is 94.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.9.

Althea Group Holdings Limited's total revenue rose by 151.6% to $5M since the same quarter in the previous year.

Its net income has increased by 0.9% to $-8M since the same quarter in the previous year.

Finally, its free cash flow grew by 61.2% to $-3M since the same quarter in the previous year.

Based on the above factors, Althea Group Holdings Limited gets an overall score of 4/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	AU
CurrencyCode	AUD
ISIN	AU0000022774

Market Cap	18M
Beta	1.53
PE Ratio	None
Target Price	0.57
Dividend Yield	None

ABOUT

Althea Group Holdings Limited

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

AGH.AU · Althea Group Holdings Limited

-

Althea Group Holdings Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Althea Group Holdings Limited using a moving average strategy